Dermatitis: Clinical Trials

26 trials for Dermatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 terminated. 26 Phase 1, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 126Terminated 26
Phase 28Terminated 8

Follow Dermatitis: new trials by email Literature Review of Dermatitis trials Research Report on Dermatitis

Trials (filtered) newest first · largest first

All 26 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis
OTC Drug for Atopic Dermatitis in Cream form - Atopic Dermatitis (AD)
Phase 1TerminatedGood Molecules, LLC32025-08-142026-05-27
Topical ENS-002 for Atopic Dermatitis in Adults
ENS-002 - Atopic Dermatitis, Atopic Dermatitis Eczema
Phase 1TerminatedConcerto Biosciences92024-09-182025-08-14
A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis
LY3872386, Prednisone, Placebo - Healthy, Atopic Dermatitis
Phase 1TerminatedEli Lilly and Company182023-11-012025-10-03
A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)
Placebo, IMG-007 - Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis
Phase 1 / Phase 2TerminatedInmagene LLC132023-08-092025-11-06
Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD)
NM26-2198, Placebo - Atopic Dermatitis
Phase 1TerminatedYellow Jersey Therapeutics AG1262023-05-102026-07-06
Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ)
Dermaprazole 1%, Dermaprazole 2% - Radiation Dermatitis, Breast Cancer
Phase 1 / Phase 2TerminatedBaylor College of Medicine32023-04-242026-02-17
Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis
XmAb27564, Placebo - Psoriasis, Atopic Dermatitis
Phase 1TerminatedXencor, Inc.232022-10-102025-12-02
A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis
LY3844583, Placebo - Healthy, Dermatitis, Atopic
Phase 1TerminatedEli Lilly and Company862022-08-112026-10-13
Targeted Investigation of Microbiome Elimination
S. hominis A 9 Product, Placebo - Atopic Dermatitis
Phase 1TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)212022-07-182024-11-12
A Study of Orally Administered IPG7236 in Healthy Adult Participants
IPG7236- Single ascending dose, IPG7236- Multiple ascending dose, Placebo (Part A) - Atopic Dermatitis
Phase 1TerminatedNanjing Immunophage Biotech Co., Ltd632022-04-072025-12-22
A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis (AD)
AR100DP1 - Dermatitis, Atopic
Phase 1 / Phase 2TerminatedArjil Pharmaceuticals LLC172020-12-082023-12-11
A Non-Drug Study Detecting And Quantifying Nocturnal Scratch Behaviors From Wrist Actigraphy Data In Adult Healthy Volunteers And Participants With Atopic Dermatitis (AD)
Wrist Actigraphy Device, Sleep Headband - Atopic Dermatitis
Phase 1TerminatedAbbVie162020-02-172022-02-15
Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis
DS-2741a, Placebo - Atopic Dermatitis
Phase 1TerminatedDaiichi Sankyo Co., Ltd.82020-01-132021-06-22
Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis
Clobetasol propionate 0.05% Topical Oil - Atopic Dermatitis
Phase 1 / Phase 2TerminatedHill Dermaceuticals, Inc.82019-09-092021-06-23
Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis
KHK4323 IV/S, KHK4323 SC/S, KHK4323 IV/M - Atopic Dermatitis
Phase 1TerminatedKyowa Kirin Co., Ltd.52019-02-222020-01-28
A Study to Test Safety, Tolerability, and the Way the Body Absorbs, Distributes, and Gets Rid of a Study Drug Called MOR106, in Healthy Subjects and in Patients With Moderate to Severe Atopic Dermatitis
MOR106, Placebo - Healthy, Atopic Dermatitis
Phase 1TerminatedLakefront Biotherapeutics NV442018-08-132020-03-18
Topical Use of Difinsa53™ to Prevent Radiation Dermatitis
Difinsa53, Aquaphor - Radiodermatitis
Phase 1 / Phase 2TerminatedProTechSure Scientific, Inc.132015-08-012017-10-06
A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003)
MK-8226, Placebo - Atopic Dermatitis
Phase 1TerminatedMerck Sharp & Dohme LLC652012-12-212019-03-15
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
REGN846 - Pruritus, Atopic Dermatitis
Phase 1 / Phase 2TerminatedRegeneron Pharmaceuticals192012-06-012013-10-28
Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.
LEO 29102, LEO 29102 Cream Vehicle - Atopic Dermatitis
Phase 1TerminatedLEO Pharma582011-09-012025-02-24

Showing 20 of 26. Sign in to see all of them.

Narrower conditions

Dermatitis, Atopic (20)  ·  Eczema (4)  ·  Radiodermatitis (4)  ·  Alopecia (2)  ·  Breast Neoplasms (2)  ·  Psoriasis (2)  ·  Skin Diseases (2)  ·  Anus Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Immune System Diseases (1)  ·  Lymphoma, T-Cell, Cutaneous (1)  ·  Mycosis Fungoides (1)  ·  Pruritus (1)  ·  Stevens-Johnson Syndrome (1)

Broader conditions

Skin and Connective Tissue Diseases (26)  ·  Skin Diseases (24)  ·  Hypersensitivity (21)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (20)  ·  Genetic Diseases, Inborn (20)  ·  Hypersensitivity, Immediate (20)  ·  Immune System Diseases (20)  ·  Skin Diseases, Eczematous (20)  ·  Skin Diseases, Genetic (20)  ·  Neoplasms (5)  ·  Neoplasms by Site (4)  ·  Radiation Injuries (4)  ·  Wounds and Injuries (4)  ·  Pathological Conditions, Signs and Symptoms (3)

Interventions

Norepinephrine (2)  ·  2-(6-(2-(3,5-dichloro-4-pyridyl)acetyl)-2,3-dimethoxyphenoxy)-N-propylacetamide (1)  ·  Clobetasol (1)  ·  Fibroblast Growth Factor 7 (1)  ·  Fluorouracil (1)  ·  Interleukin 1 Receptor Antagonist Protein (1)  ·  Mitomycin (1)  ·  Nonprescription Drugs (1)  ·  Oils (1)  ·  Petrolatum (1)  ·  Prednisone (1)  ·  Radiotherapy (1)  ·  dimethicone (1)  ·  tempol (1)

Sponsors

Eli Lilly and Company (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  ProCertus BioPharm, Inc (2)  ·  AbbVie (1)  ·  Arjil Pharmaceuticals LLC (1)  ·  Baylor College of Medicine (1)  ·  Brett King (1)  ·  Concerto Biosciences (1)  ·  Daiichi Sankyo Co., Ltd. (1)  ·  Good Molecules, LLC (1)  ·  Hill Dermaceuticals, Inc. (1)  ·  Inmagene LLC (1)  ·  Kyowa Kirin Co., Ltd. (1)  ·  LEO Pharma (1)  ·  Lakefront Biotherapeutics NV (1)

Countries

United States (18)  ·  Germany (4)  ·  Canada (3)  ·  Japan (3)  ·  Poland (2)  ·  Australia (1)  ·  Finland (1)  ·  Spain (1)  ·  Taiwan (1)  ·  Ukraine (1)  ·  United Kingdom (1)

Top investigators

Bernardo Cervantes, PhD (1)  ·  Bethany M Anderson, MD (1)  ·  Daniel A Hamstra, MD, PhD (1)  ·  Deborah E Citrin, M.D. (1)  ·  Diamant Thaci, MD (1)  ·  Helen Timmis, MB CHB (1)  ·  James F Cleary, MBBS (1)  ·  John J Voorhees, MD (1)  ·  Joshua D Milner, M.D. (1)  ·  Joshua Petit, MD (1)

Results publications

PMID 18645136, PMID 29273054

NIH funding

2018 (1), 2023 (1)